What question did this study set out to answer?

This research aims to determine the impact of anaemia on morbidity and mortality in patients with congestive heart failure.

July 1, 2005Nephrology Dialysis TransplantationOpen Access

Anaemia as a contributor to morbidity and mortality in congestive heart failure

View Full Paper

Ask AI

Bookmark

Why the study?

Does correction of anaemia with erythropoietin and intravenous iron improve outcomes in patients with congestive heart failure?

Population

Patients with congestive heart failure (CHF) and anaemia

Design

Review

Authors

DWDov WexlerUniversity of Siena DSDonald S. SilverbergHeart Failure / Cardiomyopathy MBMiriam BlumTufts University

Discussion

Member takes

Implication

May support anaemia correction in CHF; leaves open confirmation of benefits in prospective RCTs before practice change.

Key Points

This research aims to determine the impact of anaemia on morbidity and mortality in patients with congestive heart failure.
Examined the presence of anaemia in CHF patients and its correlation with various health parameters.
Investigated the effects of subcutaneous erythropoietin and intravenous iron on health outcomes.
Proposed a collaborative treatment approach involving nephrologists and cardiologists.
Anaemia was identified in approximately 40% of CHF cases, leading to decreased cardiac function and increased mortality.
Correction of anaemia showed improvements in cardiac status and quality of life.
A relationship was established between CHF, chronic kidney insufficiency, and anaemia, emphasizing the need for early intervention.

Structured PICO

Does correction of anaemia with erythropoietin and intravenous iron improve outcomes in patients with congestive heart failure?

Population

Patients with congestive heart failure (CHF) and anaemia

Intervention

Subcutaneous erythropoietin, with or without intravenous iron

Anaemia is a significant contributor to morbidity and mortality in CHF, and its correction with erythropoietin and iron may improve clinical and functional outcomes, highlighting the importance of managing the cardio-renal syndrome.

Limitations

Requires confirmation by larger randomized, controlled, double-blind studies

Cite This Study

Wexler et al. (2005) studied this question.

synapsesocial.com/papers/6a703e6d6c240de38cdbbade https://doi.org/10.1093/ndt/gfh1101

Topics

Heart failure HFrEF treatment Heart failure hospitalization

View Full Paper

Ask AI

Bookmark

Anaemia as a contributor to morbidity and mortality in congestive heart failure

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Topics

Anaemia as a contributor to morbidity and mortality in congestive heart failure

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Also Consider

Topics

Also Consider